Back
ESC2025 Premium Access

LOw-dose RAbeprazole therapy for reducing gastrointestinal events in patients with High Bleeding Risk (LORA-HBR): a prospective, multicenter, interventional study

Session: Anticoagulation pharmacotherapy updates
Topic: Cardiovascular Pharmacotherapy
Speaker: Doctor E. Park (Seoul, KR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Eun Jin Park

Korea University Guro Hospital, Seoul (Korea (Republic of))
0 follower

4 more presentations in this session

Trends and outcomes of direct oral anticoagulant use in patients with cancer: a nationwide cohort study

Speaker: Doctor A. Holt (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Long-term outcomes of direct oral anticoagulants versus warfarin for chronic thromboembolic pulmonary hypertension: a reconstructed individual patient data meta-analysis

Speaker: Doctor A. Chng (Singapore, SG)

Access
Abstract
Slides
Video
Like
Thumbnail

Effectiveness and safety of direct oral anticoagulants versus vitamin k antagonists in patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis

Speaker: Mr K. Chagas (Itaperuna, BR)

Access
Abstract
Slides
Video
Like
Thumbnail

The efficacy and safety of direct oral anticoagulants compared to warfarin for LV thrombus resolution

Speaker: Doctor S. Azevedo (Lisbon, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Anticoagulation pharmacotherapy updates

Speakers: Doctor E. Park, Doctor A. Holt, Doctor A. Chng, Mr K. Chagas, Doctor S. Azevedo
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources